Article Summary
邹鑫 程少毅 李小飞 周勇安 韩勇 李哲 卢强.肺癌生存质量量表在晚期肺癌中使用的研究进展[J].现代生物医学进展英文版,2014,14(12):2364-2368.
肺癌生存质量量表在晚期肺癌中使用的研究进展
Progresses and Perspectives of The Lung Cancer Quality of LifeQuestionnaire in Advanced Lung cancer
  
DOI:
中文关键词: 肺癌生存质量量表  晚期肺癌  研究进展
英文关键词: Lung cancer quality of life questionnaire  Advanced lung cancer  Progresses and Perspectives
基金项目:陕西省自然科学基金(2012JM4022)
Author NameAffiliation
ZOU Xin, CHENG Shao-yi, LI Xiao-fei, ZHOU Yong-an, HAN Yong, LI Zhe,LU Qiang 第四军医大学唐都医院胸腔外科
第四军医大学学员一旅
陕西省西安市第九医院 
Hits: 660
Download times: 2903
中文摘要:
      近几年来,肺癌的发病率呈现逐年上升的趋势,成为癌症中的头号杀手。临床上针对不同类型肺癌有不同的治疗策略,由于 临床上大部分病人在确诊为肺癌时已经为晚期,对于常规治疗方法难以达到效果时,关注肺癌患者的生存质量就显地尤为必要。 肺癌生存质量量表可以反映病人临床治疗后的生存质量状况,达到反馈治疗效果的目的。在临床实验中使用肺癌生存质量量表 可以帮助临床医师制定最优化的治疗方案。国际上的研究大多不是以生存质量为主要终点的研究,生存质量也不能全面的反映 病人预后的状况,希望在今后的研究中,肺癌生存质量量表能够在临床中的使用更加普及、更加全面。本文就肺癌生存质量量表 在晚期肺癌中使用的研究进展作一综述,以期更加促进我们对于晚期肺癌患者生存质量的思考与关注,更有利于适合我国国情 的生存质量量表的研究和发展。
英文摘要:
      Lung cancer is a rising epidemic and remains the leading cause of cancer death in both men and women recently, and is becoming the first killer among the cancer. There are many different therapies for different kind of lung cancer in clinical practice, Most patients are diagnosed at an advanced stage without curative treatment options. It is essential to focus on the patients'quality of life when a cure is unattainable. Patient quality of life (QOL) prior to cancer treatment is known to be a strong predictor of survival and toleration of treatment toxicities. The usage of quality of life questionnaire obtained in the context of randomized controlled trials may help guide selection of optimal treatment by the clinician. The quality of life as the primary endpoint are not widely used in most research, and the quality of life can not reflect on the patient prognosis. We hope the lung cancer quality of life questionnaire would be used more commonly and comprehensive in cilincal practice. The aim of this review is mainly focus the progresses and perspectives of the lung cancer quality of life questionnaire in advanced lung cancer.
View Full Text   View/Add Comment  Download reader
Close